概括
细胞毒性T淋巴细胞 (CTLs) 使用其表面的特定T200蛋白修饰来破坏细胞. 这些修饰,仅限于激活的T细胞,对于CTL功能至关重要,可以被抗体阻止.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 细胞毒性T淋巴细胞 (CTLs) 上的血膜糖蛋白调节细胞的结合和破坏.
- 不同的表面蛋白质配置,特别是高分子量 (Mr) 蛋白质,将成熟的CTL与天真或非细胞分解性T细胞区分开来,这表明它们在激活或溶解中的作用.
研究的目的:
- 研究细胞毒性T淋巴细胞 (CTLs) 中高Mr膜蛋白的特定修饰.
- 为了确定涉及T细胞激活和细胞分解功能的CTL特异性表面蛋白质变化.
主要方法:
- 产生针对CTL克隆细胞表面蛋白的单克隆抗体.
- 使用单克隆抗体识别新抗原决定因素对T200蛋白质修饰的分析.
- 对抗体阻断细胞分解活性的评估.
主要成果:
- CTLs在T200膜蛋白中表现出特定的修饰.
- 这些T200新抗原决定因素仅在激活的T细胞上发现,高度在CTLs上.
- 针对这些新型表位体的抗体阻断了CTL介导的细胞分解活性.
结论:
- T200蛋白经历CTL特异性修饰,这些修饰表明T细胞激活.
- 这些修改后的T200表位对CTL细胞的细胞毒性功能至关重要.
- 针对这些修改提供了一个潜在的策略来调节CTL活动.
相关概念视频
Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


